|
This analytical report from TestAmerica details the testing of nine water samples for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), confirming compliance with laboratory quality standards and providing results for the samples received on March 18, 2008.
|
2008 |
AR226-3853
|
b1rGdKJGBnB5jYe2oBYn3mD6 |
27 |
|
The document discusses the delivery of analytical files related to water samples from a well (D7F290273) and includes a .csv file containing data, but does not provide PDF files for the remaining samples.
|
2008 |
AR226-3855
|
EdkYr1mjD7x0QqK47K03Ky3an |
18 |
|
This analytical report from TestAmerica Denver details the compliance and results of PFOA and PFOS analyses conducted on three samples received on December 14, 2007, confirming that all data met laboratory QA/QC protocols.
|
2008 |
AR226-3856
|
06Y88qMQ4vXG16Bm8Rzqvakwm |
20 |
|
The document is a cover letter from the Sayreville Water Department to the New Jersey Department of Environmental Protection, enclosing PFOA sampling results and indicating compliance with laboratory quality standards.
|
2008 |
AR226-3858
|
50y1Me1YkazrERZ5X2Mpy2bDN |
20 |
|
The document reports the results of PFOA and PFOS sampling conducted by the Sayreville Water Department, indicating detected levels of 0.0075 µg/L for PFOA and 0.0042 µg/L for PFOS at the Bedminster Plant, and 0.0070 µg/L for PFOA and 0.0034 µg/L for PF
|
2008 |
AR226-3859
|
OEm0JmB4Obpr7b12L9mzMdJ8j |
5 |
|
The document contains the PFOA/PFOS analytical results for the City of Salem's third round of samples collected in the first quarter of 2008, as communicated by Fred Mucci and provided by QC Laboratories.
|
2008 |
AR226-3862
|
v60ejV6QQGqe8j4JGe8vZ50Rw |
22 |
|
The document discusses the results of the fourth round of PFOA/PFOS sampling conducted in the City of Salem for the second quarter of 2008, and includes a request for guidance on whether to continue sampling for these substances.
|
2008 |
AR226-3863
|
MM27EmyZwGOw3gyr2Ew9Vrrnz |
19 |
|
The document discusses a study examining the association between serum perfluoroalkyl chemicals, including PFOA and PFOS, and glucose homeostasis and metabolic syndrome in adolescents and adults.
|
2008 |
AR226-3874
|
Lpk1nMX9wRGbnYqNRbN6KpgD3 |
13 |
|
This document is a TSCA Section 8(e) Substantial Risk Notice from 3M regarding the development of a testing method for determining whether fluoropolymers can generate perfluorooctanoic acid (PFOA) when heated, submitted to the EPA as part of ongoing assessments of fluorochemical exposure pathways.
|
2008 |
AR226-3939
|
wrObn94o2yBgB2z7V1vKEawG3 |
39 |
|
The document is an interim report detailing the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in surface water and sediment samples as part of the 3M Decatur Monitoring Program, conducted by MPI Research, Inc. under EPA TSCA Good Laboratory
|
2008 |
AR226-3828
|
jmLjR2dqe4BDz13DOVVej1p6R |
107 |
|
This interim report details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, conducted by MPI Research, Inc. in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2008 |
AR226-3828
|
EdrzqJ0EBoMeB1Q8KZg76ovnR |
197 |
|
The document is an interim report detailing the analysis of Perfluorobutane sulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctane sulfonate (PFOS) in various environmental samples from the 3M Decatur Monitoring Program, conducted in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2008 |
AR226-3828
|
zoejgQKv3wxjemEe6kX8Vq1Dz |
135 |
|
The document is an analytical report prepared by Severn Trent Laboratories for Weston Solutions, Inc. regarding a confidential investigation into water samples collected on January 26, 2005, as part of the Decatur - FC investigation, but does not specify findings related to PFOA or PFOS.
|
2008 |
AR226-3828
|
ypOK1g3bayjkJRbY1ZYq1knYn |
36 |
|
The document is a final report from the 3M Environmental Laboratory detailing the analysis of perfluorinated compounds, including PFOA and PFOS, in aqueous samples collected from the 3M Decatur facility for quarterly monitoring under NPDES Permit Number AL0000205.
|
2008 |
AR226-3828
|
gEvGxvpLORmRLpO8gZB8wRk5e |
13 |
|
The document is a final report from the 3M Environmental Laboratory detailing the analysis of PFBA, PFOA, PFBS, PFOS, FBSA, and FOSA in aqueous samples collected from 3M's Decatur, Alabama facility as part of their NPDES permit monitoring for the second quarter of 2008.
|
2008 |
AR226-3828
|
p180dBzBo8Mog73YYY5wXZ87 |
12 |
|
The document is a final laboratory report from 3M Environmental Laboratory detailing the analysis of PFBA, PFOA, PFBS, PFOS, FBSA, and FOSA in aqueous samples collected from the 3M Decatur facility for quarterly monitoring under NPDES Permit Number AL0000205.
|
2008 |
AR226-3828
|
Nw4XbQBKNgME4KebjNdQ8DOD |
12 |
|
This document is a data report prepared by Weston Solutions, Inc. for 3M Company and Dyneon, LLC, detailing the environmental monitoring program related to perfluorinated sulfonates at the 3M Decatur, Alabama facility as of September 2008.
|
2008 |
AR226-3828
|
99XwEKL5xrmroE7VyY3GXL6Np |
407 |
|
This interim report details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, conducted by MPI Research, Inc. in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2008 |
AR226-3828
|
DZv9vGY8rvjbpL2vYymbgozM |
149 |
|
The document is a final report from the 3M Environmental Laboratory detailing the analysis of PFBA, PFOA, PFBS, PFOS, FBSA, and FOSA in aqueous samples collected from the 3M Decatur facility as part of quarterly monitoring under NPDES Permit Number AL0000205.
|
2007 |
—
|
MoRD4MJgeqZ3NKyLbLap4Lrpz |
13 |
|
The document is a final report from the 3M Environmental Laboratory detailing the analysis of PFBA, PFOA, PFBS, PFOS, FBSA, and FOSA in aqueous samples collected from 3M's Decatur, Alabama facility as part of quarterly monitoring under NPDES Permit Number AL0000205.
|
2007 |
—
|
MGME5V2kNvMkg53Q1M9KNRpo9 |
13 |
|
The document is a final report from the 3M Environmental Laboratory detailing the analysis of PFBA, PFOA, PFBS, PFOS, FBSA, and FOSA in aqueous samples collected from 3M's Decatur, Alabama facility as part of their quarterly monitoring under NPDES Permit Number AL0000205.
|
2007 |
—
|
YDeKDYKg9kQKxZ0xZ6K3eMnJE |
11 |
|
Interim Report #19 details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, conducted by Exygen Research in compliance with EPA TSCA Good Laboratory Practice Standards
|
2007 |
—
|
Lperp784aZnOr0KDzjaQnE903 |
122 |
|
Interim Report #26 details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, conducted by Exygen Research in compliance with EPA TSCA Good Laboratory Practice Standards
|
2007 |
—
|
GKJqdnGmpQJ51MadyXB39vkKn |
118 |
|
Interim Report #27 details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental matrices for the 3M Decatur Monitoring Program, conducted by Exygen Research in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2007 |
—
|
wq2YXzRxgJan7QB03rVwZd0Kd |
119 |
|
This is a Severn Trent Laboratories analytical report (Job 249891) prepared for Weston Solutions regarding the confidential Decatur project, detailing water sample analyses for total dissolved and suspended solids.
|
2007 |
—
|
37rjZagVBkRB6DgDMpLGzMXEn |
27 |
|
The Severn Trent Laboratories analytical report for Weston Solutions, Inc. details sediment samples collected on December 13 and 15, 2006, as part of the Confidential Decatur project, but does not specify any findings related to PFOA or PFOS.
|
2007 |
—
|
7qMLEJneMjNEznZpYbNg9mxE |
18 |
|
Interim Report #28 details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental matrices for the 3M Decatur Monitoring Program, conducted by Exygen Research in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2007 |
—
|
npzbd7mEyNv875G2Jmo9XVrLG |
118 |
|
Interim Report #29 details the reanalysis of soil and sludge samples for Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) as part of the 3M Decatur Monitoring Program, conducted by MPI Research in compliance with EPA TSCA Good Laboratory Practice Standards
|
2007 |
—
|
gDZaGyZogj32kGENjJe5ya72a |
131 |
|
This interim report details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental matrices for the 3M Decatur Monitoring Program, conducted by Exygen Research in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2007 |
—
|
V3pmDyV4zQn28OjgRbpxjzXrZ |
121 |
|
The document is a TSCA 8(e) Substantial Risk Notice regarding PFOA, indicating that a final report will be forwarded to the EPA once available, highlighting potential risks associated with the substance.
|
2007 |
AR226-3829
|
VJ6KppLLXL2q9BEqK708Nb7Gg |
1 |
|
3M notified the EPA of a substantial risk regarding an experimental fluorinated surfactant salt, indicating it is a dermal sensitizer based on a mouse local lymph node assay that showed significant immune response changes.
|
2007 |
AR226-3830
|
JN055Q6q69KwjnZg6BmOJm27r |
1 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the US EPA regarding PFOA, indicating potential risks associated with the substance.
|
2007 |
AR226-3832
|
emEpQgLBRq85dV3X7qg78zoGe |
1 |
|
The document details a Local Lymph Node Assay (LLNA) study conducted by MB Research Laboratories on the test article MTDID 6675.1, sponsored by 3M Corporate Toxicology & Regulatory Services, to evaluate the skin sensitization potential of the compound in female CBA/J mice.
|
2007 |
AR226-3831
|
mBYBmEG2yYb8eaGnd3LmgbG90 |
57 |
|
The document discusses the results of a developmental toxicity screening study of the test article MID 6675 in rats, conducted by Charles River Laboratories, which involved administering various dosage levels of the test substance via oral gavage to evaluate its effects on presumed pregnant rats.
|
2007 |
AR226-3833
|
b5LBjXpB5G47k61nEzqGg0gRk |
123 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice to the EPA reporting significant increases in liver and adrenal weights in male and female rats, respectively, following a 28-day oral gavage toxicity study on an experimental fluorinated surfactant salt.
|
2007 |
AR226-3837
|
jmpp1QpNgwZDzrgaQxn4Qq3rk |
1 |
|
This is a fax transmission from Robert A. Bilott, Esq. of Taft, Stettinius & Hollister LLP, dated June 10, 2002, sent to multiple recipients including various officials from the West Virginia Department of Environmental Protection and the U.S. Environmental Protection Agency.
|
2007 |
AR226-1098
|
65YzM6pZ655v5G6m6Zkqyw17m |
19 |
|
This document is a letter from Robert A. Bilott to Mary Dominiak of the EPA, submitting various documents related to PFOA for inclusion in Administrative Record 226, including critiques and press releases about C-8 levels in Ohio community water supplies.
|
2007 |
AR226-1155
|
RjJBKmp0aqXdnOvK2rk42yRBz |
2 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP regarding the submission of additional information to the IRIS Submission Desk related to Perfluorooctanoic Acid (PFOA) and its potential toxicological effects, referencing several scientific studies.
|
2007 |
AR226-1162
|
6wO6B48VkwwoYnmodJR1Oz8qo |
2 |
|
This is a letter from Taft, Stettinius & Hollister LLP, dated December 16, 2002, transmitting documents for inclusion in Administrative Record 226 related to environmental matters.
|
2007 |
AR226-1163
|
6BLyaRoKm1JMw3ya0mQ95odZE |
2 |
|
This document is a letter from Taft, Stettinius & Hollister LLP addressing the U.S. EPA regarding human health threats from releases of PFOA/APFO/C-8 in West Virginia and Ohio, serving as a supplement to a previous correspondence on the same topic.
|
2007 |
AR226-1307
|
5LmwL2qK3MaO2DKamGEw2LZQ5 |
3 |
|
The document is a letter from Robert A. Bilott to various EPA officials regarding a class action lawsuit against E.I. duPont de Nemours and Company for the contamination of drinking water with perfluorooctanoate (PFOA) in West Virginia and Ohio.
|
2007 |
AR226-1173
|
x5nYKzbpp1v18z92J8kB56e8J |
4 |
|
This document is a communication from the law firm representing plaintiffs in a lawsuit against E.I. duPont de Nemours and Company regarding issues related to PFOA.
|
2007 |
AR226-1175
|
RpZYzQ6mw28eQwV8aKmB212jE |
3 |
|
This letter discusses the West Virginia Department of Environmental Protection's decision not to independently verify the C-8 (PFOA) toxicity results obtained by DuPont's contractor, Exygen, and confirms the denial of a request to appoint a representative to the C-8 Assessment of Toxicity Team under a consent order.
|
2007 |
AR226-1178
|
x550KZ3gL2wd2K3NVQDY13p0J |
2 |
|
The document is a correspondence from Taft, Stettinius & Hollister LLP requesting permission to speak with EPA and ATSDR representatives regarding the C-8 (PFOA) Assessment of Toxicity Team's screening levels for C-8 established under a Consent Order with DuPont, highlighting the law firm's representation of plaintiffs in litigation against DuPont.
|
2007 |
AR226-1184
|
dQgvkMB9kM2XDGxVb9Zq75E9q |
2 |
|
This letter from Taft, Stettinius & Hollister LLP addresses document production issues with the West Virginia Department of Environmental Protection (WVDEP) related to outstanding requests, indicating that there may be recently-generated documents concerning PFOA that have not yet been produced.
|
2007 |
AR226-1185
|
g2XkO2rk5RXgkemLYbL6zK49 |
18 |
|
The document is a correspondence from Taft, Stettinius & Hollister LLP regarding a class action lawsuit against E.I. duPont de Nemours and Company for allegedly releasing ammonium perfluorooctanoate (C-8) into the environment from its Washington Works facility in Wood County, West Virginia.
|
2007 |
AR226-1189
|
rpNmZZ0DD8MkajZe34mK5gzRe |
120 |
|
The document is a notification letter from Taft, Stettinius & Hollister LLP regarding a human health threat arising from releases of PFOA/APFO/C-8 in West Virginia and Ohio, addressed to various officials at the U.S. Environmental Protection Agency.
|
2007 |
AR226-1216
|
2qvj3eNGBnkJRZ3jgbanwOa7R |
60 |
|
The document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA, submitting various reports related to PFOA monitoring and assessments from DuPont and other sources for inclusion in Administrative Record 226.
|
2007 |
AR226-1232
|
XOLDDwN4NJxLe20woZbaBj74d |
2 |
|
This document is a letter from Taft, Stettinius & Hollister LLP to the EPA, submitting various reports related to the effects of PFOA contamination in the Dry Run Creek area of Wood County, West Virginia, for inclusion in Administrative Record 226.
|
2007 |
AR226-1239
|
1DBjnEB04Z6enLga1mkYEr55 |
2 |
|
This letter from Taft, Stettinius & Hollister LLP to the EPA provides supplemental information regarding E.I. duPont de Nemours and Company's knowledge of health effects related to exposure to ammonium perfluorooctanoate (PFOA) and its implications for public health and safety.
|
2007 |
AR226-1441
|
j2364meYzQO1Lb4MqzmXM5nO |
11 |
|
The document is a communication from Taft, Stettinius & Hollister LLP to the EPA regarding DuPont's reporting under TSCA Section 8(e) about PFOA, specifically addressing findings related to eye defects in cattle exposed to contaminated water.
|
2007 |
AR226-1472
|
q379OGONvokM07Jy9pkOyp5K5 |
2 |
|
The document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA, submitting additional copies of previously included documents related to PFOA for Administrative Record 226, following DuPont's confidentiality claims.
|
2007 |
AR226-1244
|
mVnN4L2DXkRkr7zM3bLpmw1k |
1 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA regarding the human health threat posed by PFOA releases from the DuPont Washington Works Plant in West Virginia, providing supplemental information on the health evaluations of workers exposed to PFOA.
|
2007 |
AR226-1544
|
da8KVrB7N8Gb8zg7RDExdLoE6 |
2 |
|
This document is a letter from Taft, Stettinius & Hollister LLP to the EPA, providing additional information regarding E.I. duPont de Nemours and Company's knowledge of health effects related to exposure to ammonium perfluorooctanoate (PFOA) at the time they obtained pregnancy outcome and drinking water contamination data.
|
2007 |
AR226-1554
|
3JdgMGLLJ0m6r10aJLp7MM96J |
8 |
|
This document is a correspondence from Robert A. Bilott to the EPA regarding the submission of DuPont documents related to the presence of PFOA in various production processes and products, highlighting concerns about its potential threat to human health and the environment.
|
2007 |
AR226-1645
|
R8QLo5B8Gg0M1nBX5BOwkvvv |
3 |
|
This document is a letter from Taft, Stettinius & Hollister LLP to the EPA regarding DuPont's reporting of PFOA drinking water contamination data under TSCA, including additional documents and emails that discuss the involvement of DuPont and 3M's counsel in the preparation of a report proposing a safety level for PFOA in drinking water.
|
2007 |
AR226-1675
|
GK32950mkE32KXqMeZpO014y7 |
2 |
|
The document reports the results of PFOA serum testing conducted by DuPont and Exygen on twelve individuals from a community near DuPont's Washington Works facility, revealing that all participants were exposed to PFOA through contaminated drinking water averaging approximately 0.5 ppb.
|
2007 |
AR226-1863
|
k61a6no2VavLrwzQrKj6Y37Kb |
3 |
|
The document provides the results of PFOA serum testing for twelve individuals from a community near DuPont's Washington Works facility, indicating exposure to PFOA through contaminated drinking water with an average concentration of approximately 0.5 ppb.
|
2007 |
AR226-1870
|
qde9LQ6x15M8xXkZbzj4Y76ME |
3 |
|
The document is a correspondence from Robert A. Bilott to the EPA, enclosing a letter from DuPont that provides new data on human health effects related to exposure to PFOA, requesting its inclusion in the administrative record AR-226 and OPPT-2003-0012.
|
2007 |
AR226-1886
|
1535Vb2p0z40a42ZwgxED53b5 |
1 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA, providing additional information on a PFOA human health effects study related to cancer data from individuals exposed to PFOA-contaminated drinking water near E.I. duPont de Nemours and Company's facility in West Virginia.
|
2007 |
AR226-1893
|
GmEw4DOorNQ4Dr6wqyDxYy8rn |
2 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA, providing two sets of slides from DuPont regarding preliminary results of a human health effects study on PFOA among workers at the Washington Works Plant in West Virginia.
|
2007 |
AR226-1922
|
N2kDjjeXgRR1vjJDVGdY9yVjD |
2 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA, providing additional detailed summaries of a human health effects study related to PFOA exposure from contaminated drinking water near the E.I. duPont de Nemours and Company's Washington Works Plant.
|
2007 |
AR226-1925
|
V3nvVQ3B62Qpjgbz9eXBnvez8 |
2 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP regarding a lawsuit against 3M Company related to residential exposure to perfluorochemicals, specifically PFOS and PFOA, due to their manufacturing and disposal practices in Cottage Grove, Minnesota.
|
2007 |
AR226-1955
|
2JNe4vkO4QZ3ZqDoQR3yn0kmb |
8 |
|
The document presents personal air monitoring data from the Washington Works facility, indicating PFOA levels in the Polymers Area, with a mean concentration of 0.09 ppb and a maximum of 0.56 ppb, suggesting the need for further data collection in several instances.
|
2007 |
AR226-2007
|
6wDJN740m0XRMnjwb7oOxL7BE |
2 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP to various EPA officials and state representatives, providing updates and documents related to international activities concerning PFOA and PFOS, specifically mentioning Canada's ecological risk assessment activities.
|
2007 |
AR226-3591
|
byzZO4DX9ZnwYva7v1j24M6w3 |
4 |
|
This document is a correspondence from Taft, Stettinius & Hollister LLP to the EPA, providing additional PFC exposure and monitoring data, including an addendum related to the environmental assessment program for the 3M Cottage Grove, MN facility and a news release from the Minnesota Department of Health regarding revised fish consumption advice due to PFC contamination.
|
2007 |
AR226-3627
|
MGRMojMN2mayOqVboaOGw81KL |
2 |
|
This document is a correspondence from Robert A. Bilott to various EPA and Minnesota Pollution Control Agency officials, enclosing a report from Environment Canada and Health Canada regarding consultations on a proposed action plan for perfluorocarboxylic acids, which includes PFOA and related perfluorinated compounds.
|
2007 |
AR226-3695
|
3V9zy5qBrmEJ9zJMxGrQLGvx |
2 |
|
This document is a correspondence from Roberta Bilott regarding a PFOA human health effects study, responding to requests from the EPA and other governmental entities for information on environmental and human exposures to PFOA.
|
2007 |
AR226-3694
|
MGMNMGQQbN1o1pb6krBjJ7ekz |
37 |
|
This document is a letter from Taft, Stettinius & Hollister LLP to the EPA, providing preliminary non-occupational blood data related to Perfluorooctanoic Acid (PFOA) collected from communities in West Virginia and Ohio as part of a settlement agreement, while noting the confidentiality of the study protocols established by the Science Panel.
|
2007 |
AR226-3739
|
k6mZ8Rz8noLRGBmybJ6qxrKGJ |
12 |
|
This document is a letter from Taft, Stettinius & Hollister LLP to the EPA, providing preliminary non-occupational blood data related to Perfluorooctanoic Acid (PFOA) collected from communities in West Virginia and Ohio as part of a settlement agreement with DuPont regarding residential exposure to PFOA in drinking water.
|
2007 |
AR226-3739
|
xdvVXdwbnNRy4njX6y1510by |
12 |
|
This document is a letter from Taft, Stettinius & Hollister LLP to the EPA, providing preliminary non-occupational blood data related to Perfluorooctanoic Acid (PFOA) collected from communities in West Virginia and Ohio as part of a settlement agreement involving DuPont.
|
2007 |
AR226-3739
|
gQLwma1dQ4aEaGD7GGnZEobq |
12 |
|
This is a letter from Taft, Stettinius & Hollister LLP dated February 2, 2007, providing additional perfluorochemical exposure data for Washington County, Minnesota, to various EPA and Minnesota Department of Health officials for inclusion in the EPA's Administrative Record 226.
|
2007 |
AR226-3749
|
zdGq2nLbDE7nwaL3nBL5yjDGa |
12 |
|
The Minnesota Department of Health announced the detection of low levels of perfluorobutanoic acid (PFBA) in municipal wells across six cities, indicating no immediate health risk but prompting an investigation into the contamination source.
|
2007 |
AR226-3750
|
J3Dmm05aY9jRmb5bpXwZ1ny66 |
9 |
|
The document is a correspondence from DuPont Chemical Solutions Enterprise, dated March 7, 2007, providing additional information on studies related to the global fate and exposure potential of DuPont's fluorotelomer products and their biodegradation, following a meeting with the EPA.
|
2007 |
AR226-3753
|
bO489OJgyE46Db5RmLVoZqjLg |
28 |
|
This document is a letter from DuPont's legal counsel to the EPA regarding the submission of sanitized versions of documents related to PFOA for the AR-226 public file, clarifying that the transmittal letter does not contain confidential business information.
|
2007 |
AR226-3754
|
vykXnDRKqk110q602vxzNRqaY |
2 |
|
3M submitted a corrected copy of a study report on the effects of perfluorinated alkyl sulfonates, specifically focusing on cholesterol and bile acid metabolism in transgenic mice and fatty acid conversion in rat hepatocytes, to the EPA's AR-226 docket.
|
2007 |
AR226-3757
|
DGa0jjZeaLmRX0RmvjvqNaxK5 |
4 |
|
The document is a March 7, 2007 letter from DuPont to the EPA providing additional information on a peer-reviewed study regarding the global fate and exposure potential of DuPont's Fluorotelomer products, as well as details on biodegradation studies conducted by DuPont.
|
2007 |
AR226-3756
|
o9j1nDKO2LKVLXVVoKpag6o1r |
51 |
|
The document is a March 7, 2007 letter from DuPont to the EPA providing additional information on a comprehensive, peer-reviewed study commissioned by DuPont and conducted by Environ regarding the global fate and exposure of fluorotelomer-based compounds.
|
2007 |
AR226-3755
|
a1X1xL8w5LGLNwMknVXr9Qnkb |
79 |
|
3M submitted a TSCA 8(e) substantial risk notice to the EPA regarding preliminary data indicating that perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonate (PFHS) may affect body weight, food consumption, and serum cholesterol in transgenic mice.
|
2007 |
AR226-3763
|
4QVYELa72YxkxxNZbLd5NR8ze |
1 |
|
3M notified the EPA of preliminary findings from a study indicating that perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonate (PFHS) may affect body weight, food consumption, and serum cholesterol in E3 Leiden transgenic mice.
|
2007 |
AR226-3764
|
YDRQk4eEMGqRB9mmJezQ03qny |
1 |
|
3M submitted a TSCA 8(e) substantial risk notice to the EPA, reporting preliminary findings from a study indicating that perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonate (PFHS) may affect body weight, food consumption, and serum cholesterol in transgenic mice.
|
2007 |
AR226-3765
|
nnVBYQ4qYZ9wkmvrXrvnZmJ2 |
1 |
|
3M submitted a TSCA 8(e) Substantial Risk Notice detailing the detection of Perfluorooctanoic Acid (PFOA), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in groundwater samples from residential wells near its Decatur, Alabama facility, with PFOA levels averaging 0.
|
2007 |
AR226-3766
|
Qgx0q5dwEjG1evaoO8VEbxO7k |
1 |
|
This document is a letter from DuPont Haskell Laboratory to the EPA, providing a supplement to an ongoing study on perfluorooctanoate (PFOA) that examines health status and serum biomarker exposure among employees at the DuPont Washington Works plant, reporting that while serum PFOA levels were positively associated with certain health parameters, the clinical significance of these associations is unlikely.
|
2007 |
AR226-3767
|
ZJYEgXQJa75QzJ3R5yBLnnpjJ |
2 |
|
This letter from DuPont provides a supplement to a previous submission regarding a longitudinal study on perfluorooctanoate (PFOA), indicating that increased serum PFOA levels are associated with higher total cholesterol and changes in liver function indicators among employees at the DuPont Washington Works plant, although DuPont does not consider this information to constitute substantial risk under TSCA 8(e).
|
2007 |
AR226-3768
|
mq9x01doDon6DaLkRqo7vZO6B |
2 |
|
This document is a correspondence from DuPont Chemical Solutions Enterprise detailing additional information on studies related to the global fate and exposure potential of DuPont's fluorotelomer products and their biodegradation, following a meeting with the EPA.
|
2007 |
AR226-3753
|
gbp3YY9Ve2Eoeog6zVmRxdeaG |
28 |
|
This interim report details the analysis of Perfluorooctanoic Acid (PFOA) in various environmental samples for the 3M Decatur Monitoring Program, conducted by Exygen Research in compliance with EPA TSCA Good Laboratory Practice Standards.
|
2007 |
AR226-3766
|
okRQL1bbVDQVpQyqzBDDb8n3 |
119 |
|
Interim Report #26 details the analysis of Perfluorobutanesulfonate (PFBS), Perfluorohexanesulfonate (PFHS), and Perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, conducted by Exygen Research in compliance with EPA TSCA Good Laboratory Practice Standards
|
2007 |
AR226-3766
|
6Rdde8QqOyqOKkjbQNvekgz23 |
118 |
|
3M submitted a corrected copy of their Final Report on the effects of perfluorinated alkyl sulfonates, including perfluorooctane sulfonate and perfluorooctanoic acid, on cholesterol and bile acid metabolism in mice and fatty acid conversion in rat hepatocytes, indicating the study is not confidential.
|
2007 |
AR226-3757
|
5Dk2jmrMD66ypJoJRNeOpw104 |
4 |
|
3M submitted additional data on perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), including several environmental toxicity study reports, to the EPA's Document Control Office.
|
2007 |
AR226-3769
|
KJry5VRXzkpBN3v5XDbVomw9r |
1 |
|
The document details an acute toxicity study of perfluorooctanesulfonate (PFOS) on frog tadpoles (Pseudacris crucifer), conducted under GLP conditions, with a purity of 86.9% and findings related to mortality and exposure levels over a 96-hour period.
|
2007 |
AR226-3770
|
XzdX8JBZ5D5b1ZRXaq3GD8r1J |
4 |
|
The document details an acute toxicity study of perfluorooctanesulfonate (PFOS) conducted on the freshwater amphipod Hyalella azteca, using a sample from 3M with a purity of 86.9%, and outlines the testing methods, conditions, and analytical monitoring performed over a 96-hour exposure period.
|
2007 |
AR226-3772
|
n9K9Vw6ZJmBogRDJDJ9d43kGa |
4 |
|
The document is a final report on a 96-hour static-renewal acute toxicity test of PFOS conducted with the spring peeper tadpole (Pseudacris crucifer) by Wildlife International, Ltd. for 3M Corporation, completed on April 12, 2007, in compliance with Good Laboratory Practice Standards.
|
2007 |
AR226-3771
|
zoo3wGK2VNd9wN72zjRrNaJD3 |
40 |
|
The document is a final report of a 96-hour static-renewal acute toxicity test conducted by Wildlife International, Ltd. on PFOS using the organism Hyalella azteca, sponsored by 3M Corporation, and compliant with Good Laboratory Practice standards.
|
2007 |
AR226-3773
|
MJaMg7md0NQ1Qv8K7KQpXLZ4V |
43 |
|
The document details a study on the acute toxicity of perfluorooctanesulfonate (PFOS) to the oligochaete worm (Lumbriculus variegatus), conducted by Wildlife International, Ltd., which found the test substance to have a purity of 86.9% and utilized ASTM E729-96 methodology over a 96-hour exposure period.
|
2007 |
AR226-3774
|
qk0YxE2y7b1d2b9Xm0a93RRMx |
4 |
|
This document is a final report on a 96-hour static-renewal acute toxicity test of PFOS conducted with Lumbriculus variegatus, submitted by Wildlife International, Ltd. to 3M Corporation, and compliant with Good Laboratory Practice Standards.
|
2007 |
AR226-3775
|
xjGNkmONBqxMLXdgBQgJzxdmE |
42 |
|
The document reports on a 2007 acute toxicity study of perfluorooctanoic acid (PFOA) ammonium salt, conducted on Chironomus tentans larvae, with a purity of 95.0%, to determine the no-observed-effect concentration (NOEC) based on mortality and immobility.
|
2007 |
AR226-3776
|
YrYexVmBkD4xYZGdgZKkvpkbn |
4 |
|
The document is an amended final report of a 96-hour static-renewal acute toxicity test conducted by Wildlife International, Ltd. for 3M Corporation, assessing the toxicity of PFOA on Chironomus tentans, compliant with Good Laboratory Practice Standards.
|
2007 |
AR226-3777
|
Jvd38eyEbmvzvr7xBpMQBJozB |
45 |
|
This document is a letter from DuPont's A. Michael Kaplan to the EPA's 8(e) Coordinator, submitting final reports on a 28-day immunotoxicity study of Ammonium Perfluorooctanoate (APFO) conducted on male rats and mice.
|
2007 |
AR226-3778
|
x1jQzgr7JqRD71EVz8eKX4Dkm |
1 |
|
This document is a letter from DuPont Haskell Laboratory to the EPA, providing a supplemental submission of an interim final report on a PFOA exposure assessment conducted at the Fayetteville, NC facility, aimed at measuring worker exposure and evaluating industrial hygiene controls.
|
2007 |
AR226-3781
|
wgnbj1rrJ3gKo216Eo3gKJEQE |
1 |
|
This document is a letter from DuPont's Haskell Laboratory to the EPA, submitting a report titled "Ammonium Perfluorooctanoate: Phase II. Retrospective Cohort Mortality Analyses Related to a Serum Biomarker of Exposure in a Polymer Production Plant" as a supplement to a previous submission regarding Ammonium Perfluorooctanoate (APFO).
|
2007 |
AR226-3783
|
6BNL8b13rjV3R38w5RLp2varm |
1 |